Answer
Stalevo treats adults with Parkinson’s disease who have end-of-dose motor fluctuations not stabilised on levodopa/dopa decarboxylase (DDC) inhibitor treatment.
Sources for this answer
- Stalevo Film-Coated TabletsOrion Pharma (UK) Limited · emc · SmPC §4.1 Therapeutic Indications · Version 5Document updated
Sources checked